Reference Materials for Measurable Residual Disease (MRD) Monitoring in Circulating Cell-Free DNA

Presented at AMP 2020, this poster describes RMs for the development, validation, and control of MRD assays. We designed our RMs for a tumor/normal MRD workflow as a set of three components based on our Tumor Mutational Burden (TMB) and blood TMB (bTMB) reference materials.

Improving and Standardizing TMB Assay Performance

We’re committed to your privacy. SeraCare will not share or sell your data. View our privacy policy below for details.